agilon health(US:AGL) Globenewswire·2026-01-14 15:40Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against agilon health, inc. due to allegations of violations of federal securities laws, particularly regarding misleading statements and guidance related to the company's financial performance [4][6]. Company Overview - Agilon health, inc. is publicly traded on the NYSE under the ticker AGL [4]. - The company has faced significant challenges, leading to a suspension of its previously issued full-year 2025 financial guidance [7]. Allegations and Legal Actions - The complaint against agilon health alleges that the company and its executives made false or misleading statements, including: 1. Recklessly issuing guidance for 2025 that was unlikely to be achieved due to known industry headwinds [6]. 2. Overstating the immediate positive financial impact from strategic actions taken to reduce risk [6]. 3. Providing materially false or misleading statements about the company's business and prospects [6]. - Following the release of disappointing second-quarter results on August 4, 2025, agilon health's stock plummeted by 51.5% on August 5, 2025 [7]. Class Action Details - A federal securities class action has been filed against agilon health, with a deadline of March 2, 2026, for investors to seek the role of lead plaintiff [4]. - The lead plaintiff is defined as the investor with the largest financial interest in the relief sought, who will oversee the litigation on behalf of the class [8]. Call for Information - Faruqi & Faruqi encourages anyone with information regarding agilon health's conduct, including whistleblowers and former employees, to come forward [9].